A cardiotropic formulation

Details A cardiotropic formulation A cardiotropic formulation

A - Human Necessities

61

K

A61K 38/44 (2006.01) A61K 31/7076 (2006.01) A61K 31/7084 (2006.01)

Patent

CA 2122851

The invention relates to cardiology, and provides a cardiotropic formulation, Refrarterin, including a cardiac glycoside and b-adrenergic receptor stimulant, and it further contains nicotinamide adenine dinucleotide, cytochrome C and inosine. Refrakterin provides a complete normalization of cardiac contractile force and impoves myocardial compenstion potential in well-defined and severe conditions of heart failure.

Affiliated with

Also associated with

Rating

A cardiotropic formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A cardiotropic formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A cardiotropic formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1351617